Phibro Financial Statements From 2010 to 2026

PAHC Stock  USD 38.37  1.07  2.87%   
Phibro Animal's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Phibro Animal's valuation are provided below:
Gross Profit
443 M
Profit Margin
0.0484
Market Capitalization
1.6 B
Enterprise Value Revenue
1.5802
Revenue
1.4 B
We have found one hundred twenty available trending fundamental ratios for Phibro Animal Health, which can be analyzed and compared to other ratios and to its competitors. Investors should ensure to check out all of Phibro Animal's recent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

Phibro Animal Total Revenue

1.57 Billion

Check Phibro Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phibro Animal's main balance sheet or income statement drivers, such as Depreciation And Amortization of 55.1 M, Interest Expense of 18.4 M or Selling General Administrative of 349.5 M, as well as many indicators such as Price To Sales Ratio of 0.87, Dividend Yield of 0.0273 or PTB Ratio of 3.19. Phibro financial statements analysis is a perfect complement when working with Phibro Animal Valuation or Volatility modules.
  
Build AI portfolio with Phibro Stock
Check out the analysis of Phibro Animal Correlation against competitors.

Phibro Animal Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 B1.6 B814.8 M
Slightly volatile
Short and Long Term Debt Total919.6 M875.8 M450 M
Slightly volatile
Other Current Liabilities146.7 M139.7 M71.1 M
Slightly volatile
Total Current Liabilities354.4 M337.5 M172.6 M
Slightly volatile
Other Liabilities39.1 M36 M42 M
Slightly volatile
Property Plant And Equipment Net478.2 M455.4 M199.1 M
Slightly volatile
Net Debt837.4 M797.5 M402.8 M
Slightly volatile
Accounts Payable166.9 M158.9 M81.4 M
Slightly volatile
Cash82.2 M78.2 M47.2 M
Slightly volatile
Non Current Assets Total664.5 M632.8 M322.2 M
Slightly volatile
Non Currrent Assets Other15.5 M18.8 M18.2 M
Pretty Stable
Other Assets27.9 M35.5 M29.9 M
Slightly volatile
Long Term Debt848.2 M807.8 M345.7 M
Slightly volatile
Cash And Short Term Investments49.8 M88.6 M62.5 M
Slightly volatile
Net Receivables275.3 M262.2 M152.6 M
Slightly volatile
Common Stock Shares Outstanding35.2 M36.6 M39.3 M
Very volatile
Liabilities And Stockholders Equity1.6 B1.6 B814.8 M
Slightly volatile
Non Current Liabilities Total944 M899 M480.3 M
Slightly volatile
Inventory536.6 M511.1 M236.3 M
Slightly volatile
Other Current Assets73.8 M70.3 M38.7 M
Slightly volatile
Other Stockholder Equity165.4 M157.5 M116.8 M
Slightly volatile
Total Liabilities1.3 B1.2 B653 M
Slightly volatile
Property Plant And Equipment Gross815 M776.2 M298.3 M
Slightly volatile
Total Current Assets978.8 M932.2 M492.6 M
Slightly volatile
Short Term Debt18.8 M29.2 M15.1 M
Slightly volatile
Intangible Assets34.9 M41.9 M44 M
Slightly volatile
Common Stock3.4 K3.6 K4.2 K
Slightly volatile
Property Plant Equipment121.5 M224.9 M145.8 M
Slightly volatile
Good Will72 M68.6 M35.7 M
Slightly volatile
Common Stock Total Equity3.6 KK4.5 K
Slightly volatile
Current Deferred Revenue2.5 M2.6 M23.8 M
Slightly volatile
Short and Long Term Debt29.2 M14.6 M79.4 M
Slightly volatile
Long Term Debt Total333.8 M520.4 M344.4 M
Slightly volatile
Capital Surpluse142.6 M156.2 M130 M
Slightly volatile
Long Term Investments10.7 M13.4 M8.8 M
Slightly volatile
Non Current Liabilities Other9.7 M10.2 M41.7 M
Slightly volatile
Net Invested Capital722.5 M1.2 B622 M
Slightly volatile
Net Working Capital386.3 M594.7 M331.1 M
Slightly volatile
Capital Stock3.2 K3.6 K3.9 K
Slightly volatile
Capital Lease Obligations38.7 M49.3 M30.2 M
Slightly volatile

Phibro Animal Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization55.1 M52.4 M30.3 M
Slightly volatile
Interest Expense18.4 M29.9 M20.5 M
Pretty Stable
Selling General Administrative349.5 M332.9 M193.6 M
Slightly volatile
Total Revenue1.6 B1.5 B891.7 M
Slightly volatile
Gross Profit482.9 M459.9 M273.4 M
Slightly volatile
Other Operating Expenses1.4 B1.4 B811.8 M
Slightly volatile
Operating Income133.4 M127 M79.3 M
Slightly volatile
Research Development28.6 M27.3 M15.4 M
Slightly volatile
EBITDA177.3 M168.9 M106.1 M
Slightly volatile
Cost Of Revenue1.1 BB618.3 M
Slightly volatile
Total Operating Expenses349.5 M332.9 M193.5 M
Slightly volatile
Income Before Tax82.1 M78.2 M55 M
Slightly volatile
Interest Income2.7 M2.4 M4.6 M
Slightly volatile
Reconciled Depreciation35.8 M52.4 M31.6 M
Slightly volatile

Phibro Animal Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation55.1 M52.4 M30.3 M
Slightly volatile
Capital Expenditures24.5 M44 M29.6 M
Slightly volatile
Sale Purchase Of Stock1.2 M1.3 M114.2 M
Slightly volatile
Begin Period Cash Flow85.3 M81.2 M46.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.870.921.2847
Slightly volatile
Dividend Yield0.02730.02160.0236
Pretty Stable
Days Sales Outstanding70.2173.8364.2111
Very volatile
Stock Based Compensation To Revenue9.0E-45.0E-48.0E-4
Pretty Stable
Capex To Depreciation0.790.761.055
Slightly volatile
EV To Sales2.441.531.79
Slightly volatile
Inventory Turnover3.432.323.0695
Slightly volatile
Days Of Inventory On Hand96.93163124
Slightly volatile
Payables Turnover6.045.847.8533
Slightly volatile
Sales General And Administrative To Revenue0.20.17150.1756
Slightly volatile
Research And Ddevelopement To Revenue0.01360.01650.016
Slightly volatile
Capex To Revenue0.02640.02660.0357
Pretty Stable
Cash Per Share0.911.711.5539
Slightly volatile
Days Payables Outstanding55.1464.7247.1746
Slightly volatile
Intangibles To Total Assets0.06440.06360.098
Pretty Stable
Net Debt To EBITDA5.645.374.4406
Pretty Stable
Current Ratio1.952.492.7743
Very volatile
Receivables Turnover4.685.125.7764
Pretty Stable
Graham Number7.912.389.0671
Slightly volatile
Capex Per Share0.450.850.7262
Slightly volatile
Revenue Per Share30.2528.821.9389
Slightly volatile
Interest Debt Per Share18.5517.6611.5706
Slightly volatile
Debt To Assets0.670.640.5769
Slightly volatile
Enterprise Value Over EBITDA14.0513.3818.4179
Slightly volatile
Operating Cycle148221186
Slightly volatile
Days Of Payables Outstanding55.1464.7247.1746
Slightly volatile
Pretax Profit Margin0.02760.04720.0603
Very volatile
Ebt Per Ebit0.580.550.747
Pretty Stable
Operating Profit Margin0.05920.07670.0826
Slightly volatile
Long Term Debt To Capitalization1.330.820.8195
Slightly volatile
Total Debt To Capitalization1.160.840.8215
Slightly volatile
Return On Capital Employed0.140.120.1317
Slightly volatile
Ebit Per Revenue0.05920.07670.0826
Slightly volatile
Quick Ratio1.061.121.5064
Pretty Stable
Cash Ratio0.180.210.2686
Very volatile
Cash Conversion Cycle108170141
Slightly volatile
Days Of Inventory Outstanding96.93163124
Slightly volatile
Days Of Sales Outstanding70.2173.8364.2111
Very volatile
Fixed Asset Turnover6.184.25.3407
Slightly volatile
Enterprise Value Multiple14.0513.3818.4179
Slightly volatile
Debt Ratio0.670.640.5769
Slightly volatile
Price Sales Ratio0.870.921.2847
Slightly volatile
Asset Turnover1.381.11.2005
Slightly volatile
Gross Profit Margin0.220.280.2957
Pretty Stable

Phibro Fundamental Market Drivers

Forward Price Earnings10.5708
Cash And Short Term Investments77 M

Phibro Upcoming Events

7th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of September 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Phibro Animal Financial Statements

Phibro Animal stakeholders use historical fundamental indicators, such as Phibro Animal's revenue or net income, to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Phibro Animal's assets and liabilities are reflected in the revenues and expenses on Phibro Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Phibro Animal Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.5 M
Total Revenue1.5 B1.6 B
Cost Of RevenueB1.1 B
Sales General And Administrative To Revenue 0.17  0.20 
Research And Ddevelopement To Revenue 0.02  0.01 
Capex To Revenue 0.03  0.03 
Revenue Per Share 28.80  30.25 
Ebit Per Revenue 0.08  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:
Check out the analysis of Phibro Animal Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.824
Dividend Share
0.48
Earnings Share
1.72
Revenue Per Share
34.541
Quarterly Revenue Growth
0.397
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.